Dinani apa ngati iyi ndi nkhani yanu yosindikiza!

Njira Yopanga Katemera wa Omicron Yalengezedwa Tsopano

Everest Medicines and Providence Therapeutics (“Providence”) yalengeza lero kuti makampani ayamba kugwira ntchito ya katemera wa COVID-19 yemwe akulunjika ku mtundu watsopano wa Omicron.

Sangalalani, PDF ndi Imelo

Asayansi ochokera m'makampani awiriwa adasanthula njira zamitundu yosiyanasiyana ya SARS-CoV-2 Omicron, ma virus omwe adasankhidwa, ndikupanga ma plasmid clones. Tikuyembekeza kuti katemera watsopano wa Omicron SARS-CoV-2 atha kupititsa patsogolo kuyezetsa kuchipatala m'masiku osakwana 100.

"Tikukhulupirira kuti ndikofunikira kupanga katemera watsopano mwachangu komanso moyenera kuti tithane ndi mtundu watsopano wa Omicron COVID-19. Tigwira ntchito limodzi ndi mabungwe owongolera ndikufufuza maphunziro oyenerera azachipatala ndi zivomerezo zowongolera kuti katemerayu agulitsidwe posachedwa. ” adatero Brad Sorenson, CEO wa Providence Therapeutics.

"Tikuyembekezera kupanga katemera watsopano wa Omicron ndi Providence, ndikubweretsa phindu la katemerayu kumadera omwe sapezekanso ndi katemera wa mRNA wamakono." adatero Kerry Blanchard, MD, PhD, Chief Executive Officer wa Everest Medicines. 

Sangalalani, PDF ndi Imelo

Ponena za wolemba

Linda Hohnholz, mkonzi wa eTN

Linda Hohnholz wakhala akulemba ndi kusintha zolemba kuyambira pomwe anayamba ntchito. Iye wagwiritsa ntchito chilakolako chobadwachi m'malo ngati Hawaii Pacific University, Chaminade University, Hawaii Children's Discovery Center, ndipo tsopano TravelNewsGroup.

Siyani Comment